China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)

Market Cap	16.40B +17.8%
Revenue (ttm)	4.22B -4.9%
Net Income	906.69M +15.0%
EPS	1.43 +14.4%
Shares Out	629.46M
PE Ratio	18.22
Forward PE	16.60
Dividend	1.38 (5.15%)
Ex-Dividend Date	Oct 13, 2025

Volume	7,200,254
Average Volume	6,275,435
Open	26.39
Previous Close	26.05
Day's Range	26.16 - 26.71
52-Week Range	21.05 - 27.75
Beta	0.13
RSI	56.37
Earnings Date	Mar 20, 2026

About SHA:600750

China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, fritillaria and loquat capsules, bezoar and snake gallbladder fritillaria liquid, and compound gold melon seed. It also provides health consumer and other products, such as nouris...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 4,182
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600750

Financial Performance

In 2025, SHA:600750's revenue was 4.22 billion, a decrease of -4.87% compared to the previous year's 4.44 billion. Earnings were 906.69 million, an increase of 15.03%.